130A — Veritas in Silico Balance Sheet
0.000.00%
Annual balance sheet for Veritas in Silico, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,689 | 1,484 | 1,549 | 2,173 | 1,825 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.33 | 35.8 | 59.1 | 21 | 8.82 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,729 | 1,547 | 1,629 | 2,232 | 1,865 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 20.4 | 47.7 | 23.6 | 14.1 | 0 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,755 | 1,599 | 1,656 | 2,249 | 1,885 |
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 70.8 | 56 | 79.9 | 39.4 | 101 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 70.8 | 56 | 79.9 | 39.4 | 101 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,684 | 1,543 | 1,576 | 2,210 | 1,784 |
| Total Liabilities & Shareholders' Equity | 1,755 | 1,599 | 1,656 | 2,249 | 1,885 |
| Total Common Shares Outstanding |